Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison for postoperative analgesia after colorectal cancer surgery
ChiCTR2000032601Phase 4Completed
- Sponsor
- Harbin Medical University Cancer Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in postoperative pain, sleep disorder and Postoperative gastrointestinal dysfunction (POGD) (3 arms), sponsored by Harbin Medical University Cancer Hospital. Primary endpoints: gastrointestinal function recovery and sleep disorder. Started Jul 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painsleep disorderPostoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on ChiCTR2000032601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032601.